Form: EFFECT

Notice of Effectiveness

February 8, 2024

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: February 8, 2024 4:30 P.M.
Form: S-1
CIK: 0001971532
Company Name: Telomir Pharmaceuticals, Inc.
File Number: 333-275534